🇺🇸 FDA
Patent

US 9364430

Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol

granted A61KA61K31/485A61K9/0053

Quick answer

US patent 9364430 (Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol) held by Relmada Therapeutics, Inc. expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Relmada Therapeutics, Inc.
Grant date
Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/485, A61K9/0053, A61K9/006, A61K9/1635